References
- Adiga R, Nayak V. Emergence of novel SARS-CoV-2 variants in India: second wave. J Infect Dev Ctries. 2021 Nov;15(11):1578–1583. https://doi.org/10.3855/jidc.15484
- Ahmed-Abakur EH, Alnour TMS. Genetic variations among SARS-CoV-2 strains isolated in China. Gene Rep. 2020 Dec;21:100925. https://doi.org/10.1016/j.genrep.2020.100925
- Ahmed-Abakur EH, Ullah MF, Elssaig EH, Alnour TMS. In-silico genomic landscape characterization and evolution of SARS-CoV-2 variants isolated in India shows significant drift with high frequency of mutations. Saudi J Biol Sci. 2022 May;29(5):3494–3501. https://doi.org/10.1016/j.sjbs.2022.02.030
- Andreata-Santos R, Janini LMR, Durães-Carvalho R. From Alpha to Omicron SARS‑CoV‑2 variants: what their evolutionary signatures can tell us? J Med Virol. 2022 May;94(5):1773–1776. https://doi.org/10.1002/jmv.27555
- Callaway E. Beyond Omicron: what’s next for COVID’s viral evolution. Nature. 2021 Dec;600(7888):204–207. https://doi.org/10.1038/d41586-021-03619-8
- Cao C, Cai Z, Xiao X, Rao J, Chen J, Hu N, Yang M, Xing X, Wang Y, Li M, et al. The architecture of the SARS-CoV-2 RNA genome inside virion. Nat Commun. 2021 Jun;12(1):3917. https://doi.org/10.1038/s41467-021-22785-x
- CDC. Science brief: Omicron (B.1.1.529) variant [Internet]. Atlanta (USA): Centers for Disease Control and Prevention; 2021 [cited 2022 Mar 18]. Available from https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-Omicron-variant.html
- Choi JY, Smith DM. SARS-CoV-2 variants of concern. Yonsei Med J. 2021 Nov;62(11):961–968. https://doi.org/10.3349/ymj.2021.62.11.961
- Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985 Jul;39(4):783–791. https://doi.org/10.1111/j.1558-5646.1985.tb00420.x
- Gao SJ, Guo H, Luo G. Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert! J Med Virol. 2022 Apr; 94(4): 1255–1256. https://doi.org/10.1002/jmv.27491
- Gowrisankar A, Priyanka TMC, Banerjee S. Omicron: a mysterious variant of concern. Eur Phys J Plus. 2022;137(1):100. https://doi.org/10.1140/epjp/s13360-021-02321-y
- Gu H, Krishnan P, Ng DYM, Chang LDJ, Liu GYZ, Cheng SSM, Hui MMY, Fan MCY, Wan JHL, Lau LHK, et al. Probable transmission of SARS-CoV-2 Omicron variant in quarantine hotel, Hong Kong, China, November 2021. Emerg Infect Dis. 2022 Feb; 28(2): 460–462. https://doi.org/10.3201/eid2802.212422
- Hu J, Peng P, Cao X, Wu K, Chen J, Wang K, Tang N, Huang AL. Increased immune escape of the new SARS-CoV-2 variant of concern Omicron. Cell Mol Immunol. 2022 Feb;19(2):293–295. https://doi.org/10.1038/s41423-021-00836-z
- Isidoro C, Chiung-Fang Chang A, Sheen LY. Natural products as a source of novel drugs for treating SARS-CoV2 infection. J Tradit Complement Med. 2022 Jan;12(1):1–5. https://doi.org/10.1016/j.jtcme.2022.02.001
- Jia H, Wang H, Cao L, Lai Z, Cheng Z, Chen Q, Liu T, Liu X, Wen Y, Xu C, et al. Genetic analysis of a SARS-CoV-2 Omicron variant from a Chinese traveller returning from overseas. Emerg Microbes Infect. 2022 Dec;11(1):306–309. https://doi.org/10.1080/22221751.2022.2025747
- Kandeel M, Mohamed MEM, Abd El-Lateef HM, Venugopala KN, El-Beltagi HS. Omicron variant genome evolution and phylogenetics. J Med Virol. 2022 Apr;94(4):1627–1632. https://doi.org/10.1002/jmv.27515
- Kannan S, Shaik Syed Ali P, Sheeza A. Omicron (B.1.1.529) – variant of concern – molecular profile and epidemiology: a mini review. Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):8019–8022. https://doi.org/10.26355/eurrev_202112_27653
- Kannan SR, Spratt AN, Sharma K, Chand HS, Byrareddy SN, Singh K. Omicron SARS‑CoV-2 variant: unique features and their impact on pre-existing antibodies. J Autoimmun. 2022 Jan;126: 102779. https://doi.org/10.1016/j.jaut.2021.102779
- Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021 Dec;398(10317): 2126–2128. https://doi.org/10.1016/S0140-6736(21)02758-6
- Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene Rep. 2020 Jun;19:100682. https://doi.org/10.1016/j.genrep.2020.100682
- Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B, et al; Sheffield COVID-19 Genomics Group. Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020 Aug;182(4):812–827.e19. https://doi.org/10.1016/j.cell.2020.06.043
- Kumar S, Thambiraja TS, Karuppanan K, Subramaniam G. Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein. J Med Virol. 2022 Apr;94(4):1641–1649. https://doi.org/10.1002/jmv.27526
- Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 Feb;395(10224):565–574. https://doi.org/10.1016/S0140-6736(20)30251-8
- Lupala CS, Ye Y, Chen H, Su XD, Liu H. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor. Biochem Biophys Res Commun. 2022 Jan;590:34–41. https://doi.org/10.1016/j.bbrc.2021.12.079
- Mahase E. Covid-19: What do we know about omicron sublineages? BMJ. 2022 Feb;376:o358. https://doi.org/10.1136/bmj.o358
- Mallapaty S. Where did Omicron come from? Three key theories. Nature. 2022 Feb;602(7895):26–28. https://doi.org/10.1038/d41586-022-00215-2
- Mlcochova P, Kemp SA, Dhar MS, Papa G, Meng B, Ferreira IATM, Datir R, Collier DA, Albecka A, Singh S, et al.; Indian SARS-CoV-2 Genomics Consortium (INSACOG); Genotype to Phenotype Japan (G2P-Japan) Consortium; CITIID-NIHR BioResource COVID-19 Collaboration. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature. 2021 Nov;599(7883): 114–119. https://doi.org/10.1038/s41586-021-03944-y
- Mohapatra RK, Sarangi AK, Kandi V, Azam M, Tiwari R, Dhama K. Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: current global scenario. J Med Virol. 2022 May;94(5):1780–1783. https://doi.org/10.1002/jmv.27561
- Poudel S, Ishak A, Perez-Fernandez J, Garcia E, León-Figueroa DA, Romaní L, Bonilla-Aldana DK, Rodriguez-Morales AJ. Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts – what is known so far? Travel Med Infect Dis. 2022 Jan-Feb;45:102234. https://doi.org/10.1016/j.tmaid.2021.102234
- Quarleri J, Galvan V, Delpino MV. Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load. Geroscience. 2022 Feb;44(1):53–56. https://doi.org/10.1007/s11357-021-00500-4
- Rauf A, Abu-Izneid T, Khalil AA, Hafeez N, Olatunde A, Rahman M, Semwal P, Al-Awthan YS, Bahattab OS, Khan IN, et al. Nanoparticles in clinical trials of COVID-19: an update. Int J Surg. 2022 Aug;104:106818. https://doi.org/10.1016/j.ijsu.2022.106818
- Rudrapal M, Khairnar SJ, Borse LB, Jadhav AG. Coronavirus Disease-2019 (COVID-19): an updated review. Drug Res (Stuttg). 2020 Sep;70(9):389–400. https://doi.org/10.1055/a-1217-2397
- Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987 Jul;4(4): 406–425. https://doi.org/10.1093/oxfordjournals.molbev.a040454
- Saxena SK, Kumar S, Ansari S, Paweska JT, Maurya VK, Tripathi AK, Abdel-Moneim AS. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective. J Med Virol. 2022 Apr;94(4):1738–1744. https://doi.org/10.1002/jmv.27524
- Sharma V, Rai H, Gautam DNS, Prajapati PK, Sharma R. Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant. J Med Virol. 2022 May;94(5):1876–1885. https://doi.org/10.1002/jmv.27626
- Shishir TA, Naser IB, Faruque SM. In silico comparative genomics of SARS-CoV-2 to determine the source and diversity of the pathogen in Bangladesh. PLoS One. 2021 Jan;16(1):e0245584. https://doi.org/10.1371/journal.pone.0245584
- Sofi MS, Hamid A, Bhat SU. SARS-CoV-2: A critical review of its history, pathogenesis, transmission, diagnosis and treatment. Biosaf Health. 2020 Dec;2(4):217–225. https://doi.org/10.1016/j.bsheal.2020.11.002
- Tamura K, Nei M, Kumar S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci USA. 2004 Jul;101(30):11030–11035. https://doi.org/10.1073/pnas.0404206101
- Tan Z, Chen Z, Yu A, Li X, Feng Y, Zhao X, Xu W, Su X. The first two imported cases of SARS-CoV-2 Omicron variant – Tianjin Municipality, China, December 13, 2021. China CDC Wkly. 2022 Jan; 4(4):76–77. https://doi.org/10.46234/ccdcw2021.266
- Thakur V, Ratho RK. OMICRON (B.1.1.529): A new SARS-CoV-2 variant of concern mounting worldwide fear. J Med Virol. 2022 May; 94(5):1821–1824. https://doi.org/10.1002/jmv.27541
- Vardhan S, Sahoo SK. Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid. Comput Biol Med. 2022a May; 144: 105367. https://doi.org/10.1016/j.compbiomed.2022.105367
- Vardhan S, Sahoo SK. Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations. J Tradit Complement Med. 2022b Jan;12(1):44–54. https://doi.org/10.1016/j.jtcme.2021.12.002
- Wang L, Cheng G. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa. J Med Virol. 2022 Apr; 94(4): 1728–1733. https://doi.org/10.1002/jmv.27516
- Wang R, Chen J, Wei GW. Mechanisms of SARS-CoV-2 evolution revealing vaccine-resistant mutations in Europe and America. J Phys Chem Lett. 2021 Dec;12(49):11850–11857. https://doi.org/10.1021/acs.jpclett.1c03380
- Yi C, Sun X, Ye J, Ding L, Liu M, Yang Z, Lu X, Zhang Y, Ma L, Gu W, et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol. 2020 Jun;17(6):621–630. https://doi.org/10.1038/s41423-020-0458-z
- Zhang X, Wu S, Wu B, Yang Q, Chen A, Li Y, Zhang Y, Pan T, Zhang H, He X. SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance. Signal Transduct Target Ther. 2021 Dec;6(1):430. https://doi.org/10.1038/s41392-021-00852-5